Tag: Cancer: Lung
Outcomes Seem No Worse With Stereotactic RT for Brain Mets in SCLC
Survival outcomes for SCLC patients with brain metastases appear to be equitable with stereotactic radiosurgery, whole brain radiotherapy
Follow-Up Often Delayed After High-Risk Findings on Lung Cancer Screening
Patients with more severe findings less likely to have prolonged delays; current smokers had more delays than former smokers
Slight Increase Reported in Lung Cancer, Brain Tumors With Wildfire Exposure
Individuals exposed to wildfire within 50 km of residential locations in past 10 years had slightly higher incidence
Number of Mesothelioma Deaths Up Among Women From 1999 to 2020
However, age-adjusted death rate per 1 million women decreased significantly, from 4.83 to 4.15 from 1999 to 2020
Emphysema on CT Linked to Increased Risk for Lung Cancer
Pooled odds ratios for lung cancer increased with emphysema severity, and were higher for visual versus quantitative assessments on chest CT
AACR: Adding Nivolumab to Neoadjuvant Chemo Slows Resectable NSCLC
Event-free survival prolonged and percentage of patients with a pathological complete response higher with addition of nivolumab
Stage Shift Seen With CT Screening for Lung Cancer in the U.S.
Stage shift toward Stage I NSCLC observed following introduction of low-dose CT screening for lung cancer
CAC Tied to Cardiovascular Risk During Radiation Therapy for NSCLC
Patients with coronary artery calcium may have increased risk for major adverse cardiovascular events after initiation of radiation therapy
FDA Panel Rejects Lilly Cancer Drug Tested Only in China
Drug was to be used alongside chemotherapy for patients with metastatic non-small cell lung cancer
Aberrant Lipid Metabolism ID’d in Early-Stage Lung Cancer
Screening assay based on nine lipids commonly dysregulated in early-stage lung cancer
